Why VBI Vaccines Stock Jumped Today
Shares of VBI Vaccines (NASDAQ: VBIV) were jumping 12.7% higher as of 3:22 p.m. EDT on Monday. The solid gain came after the company announced it would present additional biomarker data from the ongoing phase 1/2a clinical study evaluating VBI-1901 in recurring glioblastoma at the European Society for Medical Oncology (ESMO) Virtual Congress.
VBI Vaccines is still small enough that any pipeline news is enough to cause the biotech stock to move significantly. In this case, even the expectation of positive news was sufficient to cause shares to rise.
Source Fool.com